• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
LIV
Click for more information
1.18% $2.77

Smartshares Healthcare Innovation ETF Units

watchlist Created with Sketch. Add to my watchlist

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
LIV
Ann: LIV NTA 02-07-2024 $2.79094 		07:56 0 14
07:56 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  14 
LIV
Ann: LIV NTA 01-07-2024 $2.79465 		02/07/24 0 25
02/07/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  25 
LIV
Ann: LIV NTA 27-06-2024 $2.80214 		01/07/24 0 31
01/07/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  31 
LIV
Ann: LIV NTA 26-06-2024 $2.81007 		27/06/24 0 41
27/06/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  41 
LIV
Ann: Smartshares Exchange Traded Funds - Annual Report 		27/06/24 0 33
27/06/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  33 
LIV
Ann: LIV NTA 25-06-2024 $2.81741 		26/06/24 0 36
26/06/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  36 
LIV
Ann: LIV NTA 24-06-2024 $2.79251 		25/06/24 0 28
25/06/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  28 
LIV
Ann: LIV NTA 21-06-2024 $2.75318 		24/06/24 0 31
24/06/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  31 

See All Discussions arrow Created with Sketch.

Featured News

NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
(20min delay)
Last
$2.77 		Change
-0.033(1.18%) 		Mkt cap ! n/a
Open High Low Value Volume
$2.80 $2.80 $2.77 $22.30K 8.062K

Buyers (Bids)

No. Vol. Price($)
0 27500 $2.77
 

Sellers (Offers)

Price($) Vol. No.
$2.80 27500 0
Last trade - 08.31am 03/07/2024 (20 minute delay) ?
LIV (NZSX) Chart

Top Stories

Sovereign's Kasiya project gains momentum, as Rio increases investment by 19.76%

Sovereign Metals Ltd has seen a boost to its Kasiya rutile graphite project in Malawi, as Rio Tinto increases its interest in the company.
Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring Sun Silver executive director Gerard O'Donovan discusses a 6,216 grams Fort Intercept at the Maverick Spring Silver Project from historical data and drill assessments.
Sun Silver to kick off drilling next week at 292Moz Maverick Springs silver-gold project  The company has locked in a drilling contractor to fire up a Reverse Circulation (RC) drill rig at Maverick starting on 8th of July US time. 
Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25 Uranium was one bright spot at the start of 2024, standing out against otherwise glum markets that defined 2023.
Ark Mines inks 1.5Bt Exploration Target for Sandy Mitchell REE play including NdPr; PFS due in Q4 Ark Mines has published an Exploration Target for its Sandy Mitchell REE project of up to 1.5B tonnes @ up to 1490ppm monazite equivalent

Featured News

NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.